648-649 / 1851
Addenbrooke’s 1999–2003
Tan LT, Zahra M. Clin Oncol (R Coll Radiol) 2008;20(5):358-64
0
12
24
36
48
60
SurvMths
0.0
0.2
0.4
0.6
0.8
1.0
Cum Survival
Stage II (28)
Stage III (12)
OS=69%, LC= 90%
Stage I (24)
OS=58%, LC= 78%
OS=21%, LC= 31%
Stage IVa (2)